3D Ultrasound Vascular Imaging for Breast Cancers

Overview

About this study

The goal of the project is to develop and test a new 3D Doppler technology, with enhanced vessel sensitivity than conventional Doppler, to employ tumor vascularity as a differential biomarker for improved cancer diagnosis and reduced unnecessary biopsy on benign tumors

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Adult women, ≥ 18 years of age.
  • Breast lesion and are scheduled for clinically-indicated biopsy.

Exclusion Criteria:

  • < 18 years of age.
  • Previous breast surgery or breast implant.
  • Lacking capacity to consent.
  • Pregnant or lactating.
  • Receiving cancer therapy such as chemotherapy or radiation therapy.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Shigao Chen, Ph.D.

Closed for enrollment

Contact information:

Bobbie Ott

(507) 293-0922

Ott.Bobbie@mayo.edu

More information

Publications

Publications are currently not available

Additional contact information

Cancer-related trials contact form

Phone: 855-776-0015 (toll-free)

International patient clinical studies questions